Rammelkamp Center for Education and Research, 2500 MetroHealth Dr., Cleveland, OH 44109-1998, USA.
Am J Physiol Renal Physiol. 2010 Apr;298(4):F988-96. doi: 10.1152/ajprenal.00586.2009. Epub 2010 Jan 27.
Transient receptor potential channels TRPC3 and TRPC6 are expressed in principal cells of the collecting duct (CD) along with the water channel aquaporin-2 (AQP2) both in vivo and in the cultured mouse CD cell line IMCD-3. The channels are primarily localized to intracellular vesicles, but upon stimulation with the antidiuretic hormone arginine vasopressin (AVP), TRPC3 and AQP2 translocate to the apical membrane. In the present study, the effect of various activators and inhibitors of the adenylyl cyclase (AC)/cAMP/PKA signaling cascade on channel trafficking was examined using immunohistochemical techniques and by biotinylation of surface membrane proteins. Both in vivo in rat kidney and in IMCD-3 cells, translocation of AQP2 and TRPC3 (but not TRPC6) was stimulated by [deamino-Cys(1), d-Arg(8)]-vasopressin (dDAVP), a specific V2-receptor agonist, and blocked by [adamantaneacetyl(1), O-Et-d-Tyr(2), Val(4), aminobutyryl(6), Arg(8,9)]-vasopressin (AEAVP), a specific V2-receptor antagonist. In IMCD-3 cells, translocation of TRPC3 and AQP2 was activated by forskolin, a direct activator of AC, or by dibutyryl-cAMP, a membrane-permeable cAMP analog. AVP-, dDAVP-, and forskolin-induced translocation in IMCD-3 cells was blocked by SQ22536 and H89, specific inhibitors of AC and PKA, respectively. Translocation stimulated by dibutyryl-cAMP was unaffected by AEAVP but could be blocked by H89. AVP- and forskolin-induced translocation of TRPC3 in IMCD-3 cells was also blocked by two additional inhibitors of PKA, specifically Rp-cAMPS and the myristoylated inhibitor of PKA (m-PKI). Quantification of TRPC3 membrane insertion in IMCD-3 cells under each assay condition using a surface membrane biotinylation assay, confirmed the translocation results observed by immunofluorescence. Importantly, AVP-induced translocation of TRPC3 as estimated by biotinylation was blocked on average 95.2 +/- 1.0% by H89, Rp-cAMPS, or m-PKI. Taken together, these results demonstrate that AVP stimulation of V2 receptors in principal cells of the CD causes translocation of TRPC3 to the apical membrane via stimulation of the AC/cAMP/PKA signaling cascade.
瞬时受体电位通道 TRPC3 和 TRPC6 与水通道 aquaporin-2(AQP2)一起在体内和培养的小鼠集合管细胞系 IMCD-3 的主细胞中表达。这些通道主要定位于细胞内囊泡,但在抗利尿激素精氨酸加压素(AVP)的刺激下,TRPC3 和 AQP2 易位到顶膜。在本研究中,使用免疫组织化学技术和表面膜蛋白的生物素化研究了各种激活剂和抑制剂对腺苷酸环化酶(AC)/cAMP/PKA 信号级联的影响。在体内大鼠肾脏和 IMCD-3 细胞中,[deamino-Cys(1), d-Arg(8)]-加压素(dDAVP),一种特异性 V2 受体激动剂,刺激 AQP2 和 TRPC3(但不是 TRPC6)的易位,并被[adamantaneacetyl(1), O-Et-d-Tyr(2), Val(4), aminobutyryl(6), Arg(8,9)]-加压素(AEAVP)阻断,一种特异性 V2 受体拮抗剂。在 IMCD-3 细胞中,AC 的直接激活剂 forskolin 或膜通透 cAMP 类似物二丁酰基-cAMP 激活 TRPC3 和 AQP2 的易位。IMCD-3 细胞中 AVP、dDAVP 和 forskolin 诱导的易位被 SQ22536 和 H89 阻断,分别是 AC 和 PKA 的特异性抑制剂。二丁酰基-cAMP 刺激的易位不受 AEAVP 影响,但可被 H89 阻断。在 IMCD-3 细胞中,PKA 的另外两种抑制剂,即 Rp-cAMPS 和蛋白激酶 A 的豆蔻酰化抑制剂(m-PKI),也阻断了 AVP 和 forskolin 诱导的 TRPC3 易位。使用表面膜生物素化测定法在每种测定条件下对 IMCD-3 细胞中 TRPC3 膜插入的定量,证实了免疫荧光观察到的易位结果。重要的是,用生物素化法估计的 H89、Rp-cAMPS 或 m-PKI 平均阻断 AVP 诱导的 TRPC3 易位 95.2 +/- 1.0%。综上所述,这些结果表明,AVP 刺激 CD 主细胞中的 V2 受体通过刺激 AC/cAMP/PKA 信号级联导致 TRPC3 易位到顶膜。